Skip navigation

Critical Insights on Enforcement Trends and Third Party Risk Management to Strengthen Compliance Programs

January 31-February 1, 2017
  • Miami, FL

Of all the challenges faced by pharmaceutical and biotech compliance teams, anti-corruption continues to rise as an area of extreme risk. As such, it is critical for teams to develop a thorough understanding of anti-corruption regulation at both a domestic and international level and capitalize on enforcement trends which encourage proactive management of whistleblowers and self-reporting.

CBI’s 3rd Annual Global Anti-Corruption and FCPA Compliance Congress explores strategies to improve compliance programs, focusing on key issues including third-party and distributor due diligence, HCP management and cross-border transactions. Join your peers to benchmark compliance programs and discuss
best practices to enhance monitoring, develop comprehensive
risk assessments and build robust training programs to instill a
company-wide culture of ethics.

CLE & CPE
CREDITS
AVAILABLE Pending Approval

GAIN CRITICAL INSIGHT ON PREVENTING GLOBAL ANTI-CORRUPTION INCLUDING:

  • Examine recent FCPA enforcement cases and gain insight into the evolving management of whistleblowers
  • Structure compliance programs to integrate monitorships into business activities
  • Determine best practices for the authentication and monitoring of third-party individuals and distributors in high-risk regions
  • Construct robust due diligence programs to identify and prepare for supply chain risks
  • Leverage data analytics to assist and facilitate the auditing and investigative processes
  • Discuss trends in global transparency requirements across world regions and their influence on FMV rate setting
  • Explore FCPA risks in emerging markets, including the Asia-Pacific, Latin American and African regions

PREVIOUS ATTENDEE ACCLAIM FROM CBI’S INTERNATIONAL COMPLIANCE SERIES:

Educational, important subject matters. Great to see pharma companies sharing common goals and challenges.

Compliance Manager, Jazz Pharmaceuticals

Very good topics and variety of speakers bringing different perspectives. It was great to network, discuss and hear about good practices and bring other perspectives back to my organization.

Vice President, Compliance Europe, AstraZeneca

Jan 31 – Feb 1, 2017 Courtyard Coconut Grove Miami, FL